DE69618383D1 - Dihydropyridine als NPY-Antagonisten: Piperidinderivate - Google Patents
Dihydropyridine als NPY-Antagonisten: PiperidinderivateInfo
- Publication number
- DE69618383D1 DE69618383D1 DE69618383T DE69618383T DE69618383D1 DE 69618383 D1 DE69618383 D1 DE 69618383D1 DE 69618383 T DE69618383 T DE 69618383T DE 69618383 T DE69618383 T DE 69618383T DE 69618383 D1 DE69618383 D1 DE 69618383D1
- Authority
- DE
- Germany
- Prior art keywords
- dihydropyridines
- npy
- antagonists
- piperidine derivatives
- npy antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48235395A | 1995-06-07 | 1995-06-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69618383D1 true DE69618383D1 (de) | 2002-02-14 |
DE69618383T2 DE69618383T2 (de) | 2002-09-26 |
Family
ID=23915711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69618383T Expired - Fee Related DE69618383T2 (de) | 1995-06-07 | 1996-06-05 | Dihydropyridine als NPY-Antagonisten: Piperidinderivate |
Country Status (10)
Country | Link |
---|---|
US (1) | US5668151A (de) |
EP (1) | EP0747357B1 (de) |
JP (1) | JPH093045A (de) |
AT (1) | ATE211733T1 (de) |
AU (1) | AU720923B2 (de) |
CA (1) | CA2177110A1 (de) |
DE (1) | DE69618383T2 (de) |
DK (1) | DK0747357T3 (de) |
ES (1) | ES2169774T3 (de) |
PT (1) | PT747357E (de) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU729590B2 (en) * | 1996-10-23 | 2001-02-08 | Sanofi-Aventis | Cosmetic composition containing a neuropeptide Y receptor antagonist |
EP0910565A1 (de) * | 1997-02-14 | 1999-04-28 | Bayer Corporation | Amidderivate als selektive neuropeptid-y-rezeptoren |
US6048900A (en) * | 1998-02-13 | 2000-04-11 | Bayer Corporation | Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists |
US6245817B1 (en) | 1997-02-14 | 2001-06-12 | Bayer Corporation | NPY5 receptor antagonists and methods for using same |
US6001836A (en) * | 1997-05-28 | 1999-12-14 | Bristol-Myers Squibb Company | Dihydropyridine NPY antagonists: cyanoguanidine derivatives |
DE69926919D1 (de) | 1998-12-18 | 2005-09-29 | Bristol Myers Squibb Pharma Co | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren |
KR20010101287A (ko) | 1998-12-18 | 2001-11-14 | 블레어 큐. 퍼거슨 | 케모킨 수용체 활성의 조절자로서 n-우레이도알킬-피페리딘 |
CA2350730A1 (en) * | 1998-12-18 | 2000-06-22 | George V. Delucca | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
WO2000035876A1 (en) | 1998-12-18 | 2000-06-22 | Du Pont Pharmaceuticals Company | 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity |
US6331541B1 (en) | 1998-12-18 | 2001-12-18 | Soo S. Ko | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
CA2348923A1 (en) | 1998-12-18 | 2000-06-22 | Dean A. Wacker | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
WO2000035877A1 (en) | 1998-12-18 | 2000-06-22 | Du Pont Pharmaceuticals Company | Heterocyclic piperidines as modulators of chemokine receptor activity |
US6525069B1 (en) | 1998-12-18 | 2003-02-25 | Bristol-Myers Squibb Pharma Co. | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
US6605623B1 (en) | 1998-12-18 | 2003-08-12 | Bristol-Myers Squibb Pharma Co. | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
EP1156807A4 (de) * | 1998-12-18 | 2002-04-03 | Du Pont Pharm Co | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren |
DE60023128T2 (de) | 1999-05-12 | 2006-07-06 | Ortho-Mcneil Pharmaceutical, Inc. | Pyrazolcarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen |
GB9912415D0 (en) * | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
AU764627B2 (en) * | 1999-06-21 | 2003-08-28 | Bristol-Myers Squibb Company | Dihydropyrazine derivatives as NPY antagonists |
WO2001025199A1 (fr) * | 1999-10-05 | 2001-04-12 | Takeda Chemical Industries, Ltd. | Composes d'uree, procede de production et d'utilisation de ces derniers |
EP1220836A2 (de) * | 1999-10-15 | 2002-07-10 | Bristol-Myers Squibb Pharma Company | Benzylcyklohexylamine als modulatoren der chemokin-rezeptor-aktivität |
US6784200B2 (en) | 2000-10-13 | 2004-08-31 | Bristol-Myers Squibb Pharma Company | Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
JP2003512355A (ja) | 1999-10-15 | 2003-04-02 | デュポン ファーマシューティカルズ カンパニー | ケモカイン受容体活性のモジュレータとしての二環式および三環式アミン |
US6897234B2 (en) * | 1999-12-17 | 2005-05-24 | Bristol-Myers Squibb Pharma Company | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
US20040053864A1 (en) * | 2000-01-20 | 2004-03-18 | Gerard Karsenty | Methods and compositions for control of bone formation via modulation of neuropeptide y activity |
US6531478B2 (en) | 2000-02-24 | 2003-03-11 | Cheryl P. Kordik | Amino pyrazole derivatives useful for the treatment of obesity and other disorders |
US6432960B2 (en) * | 2000-05-10 | 2002-08-13 | Bristol-Myers Squibb Company | Squarate derivatives of dihydropyridine NPY antagonists |
US6444675B2 (en) * | 2000-05-10 | 2002-09-03 | Bristol-Myers Squibb Company | 4-alkyl and 4-cycloalkyl derivatives of dihydropyridine NPY antagonists |
WO2001085173A1 (en) | 2000-05-10 | 2001-11-15 | Bristol-Myers Squibb Company | Alkylamine derivatives of dihydropyridine npy antagonists |
US6391881B2 (en) | 2000-05-19 | 2002-05-21 | Bristol-Myers Squibb Company | Thiourea derivatives of dihydropyridine NPY antagonists |
US6638950B2 (en) | 2000-06-21 | 2003-10-28 | Bristol-Myers Squibb Pharma Company | Piperidine amides as modulators of chemokine receptor activity |
AU2001273129A1 (en) | 2000-06-30 | 2002-01-14 | Bristol-Myers Squibb Pharma Company | N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
US6596724B2 (en) | 2000-07-07 | 2003-07-22 | Bristol-Myers Squibb Company | Oxadiazole and thiadiazole derivatives of dihydropyridine NPY antagonists |
US6974869B2 (en) * | 2001-09-18 | 2005-12-13 | Bristol-Myers Squibb Pharma Company | Piperizinones as modulators of chemokine receptor activity |
MXPA04002751A (es) | 2001-09-24 | 2005-09-08 | Univ Oregon Health & Science | Modificacion del comportamiento de alimentacion. |
EP1542719A4 (de) | 2001-12-05 | 2006-06-21 | Baylor College Medicine | Verfahren und zusammensetzungen zur steuerung der knochenbildung über modulation des sympathikotonus |
TW200409630A (en) * | 2002-09-12 | 2004-06-16 | Bristol Myers Squibb Co | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
US6919356B2 (en) * | 2002-09-26 | 2005-07-19 | Bristol Myers Squibb Company | N-substituted heterocyclic amines as modulators of chemokine receptor activity |
US20040152769A1 (en) * | 2002-11-09 | 2004-08-05 | Ekwuribe Nnochiri Nkem | Modified carbamate-containing prodrugs and methods of synthesizing same |
JP4806628B2 (ja) | 2003-05-05 | 2011-11-02 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤 |
AU2004290499C1 (en) | 2003-11-03 | 2011-02-24 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
US7291744B2 (en) * | 2003-11-13 | 2007-11-06 | Bristol-Myers Squibb Company | N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity |
CA2546264A1 (en) * | 2003-11-26 | 2005-06-09 | Novartis Ag | 4-phenylpiperidine derivatives as renin inhibitors |
WO2005059107A2 (en) | 2003-12-11 | 2005-06-30 | Anormed Inc. | Chemokine receptor binding compounds |
US7498346B2 (en) | 2003-12-11 | 2009-03-03 | Genzyme Corporation | Chemokine receptor binding compounds |
CA2554809C (en) | 2004-02-05 | 2014-04-29 | Probiodrug Ag | Novel n-alkyl thiourea- and thioamide-substituted imidazolyl inhibitors of glutaminyl cyclase |
EP2089383B1 (de) | 2006-11-09 | 2015-09-16 | Probiodrug AG | 3-hydroxy-1,5-dihydropyrrol-2-one derivate als inhibitoren von glutaminylcyclase zur behandlung von geschwüren, krebs und anderen krankheiten |
DK2091948T3 (da) | 2006-11-30 | 2012-07-23 | Probiodrug Ag | Nye inhibitorer af glutaminylcyclase |
CA2679446C (en) | 2007-03-01 | 2016-05-17 | Probiodrug Ag | New use of glutaminyl cyclase inhibitors |
US9656991B2 (en) | 2007-04-18 | 2017-05-23 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
MX2012002993A (es) | 2009-09-11 | 2012-04-19 | Probiodrug Ag | Derivados heterociclicos como inhibidores de ciclasa glutaminilo. |
WO2011107530A2 (en) | 2010-03-03 | 2011-09-09 | Probiodrug Ag | Novel inhibitors |
JP5688745B2 (ja) | 2010-03-10 | 2015-03-25 | プロビオドルグ エージー | グルタミニルシクラーゼ(qc、ec2.3.2.5)の複素環阻害剤 |
EP2560953B1 (de) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Hemmer der glutaminylzyklase |
ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3523950A (en) * | 1967-12-13 | 1970-08-11 | Robins Co Inc A H | Certain 4 - phenyl - 1,2,3,6 - tetrahydropyridyl-n-lower alkylene-ureas and derivatives |
DE3587851D1 (de) * | 1984-09-28 | 1994-07-21 | Byk Gulden Lomberg Chem Fab | Neue Diarylverbindungen. |
DE3500898A1 (de) * | 1985-01-12 | 1986-07-17 | Hoechst Ag, 6230 Frankfurt | Neue propionsaeureamide mit saeuresekretionshemmender wirkung, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung |
HU196755B (en) * | 1986-09-16 | 1989-01-30 | Gyogyszerkutato Intezet | Process for production of new substituated amilid derivatives and medical compositions containing them |
EP0276552A1 (de) * | 1986-12-08 | 1988-08-03 | Yamanouchi Pharmaceutical Co. Ltd. | 1,4-Dihydropyridin-Derivate und ihre Herstellung |
JPH0449237A (ja) * | 1990-06-15 | 1992-02-18 | Yamanouchi Pharmaceut Co Ltd | ホスホリパーゼa↓2阻害剤 |
WO1993006082A1 (en) * | 1991-09-13 | 1993-04-01 | Merck & Co., Inc. | Process for the preparation of 4-substituted-1,4-dihydropyridines |
GB9119983D0 (en) * | 1991-09-19 | 1991-11-06 | Erba Carlo Spa | Dihydropyridine derivatives useful in antitumor therapy |
FR2701480B1 (fr) * | 1993-02-15 | 1995-05-24 | Sanofi Elf | Composés à groupe sulfamoyle et amidino, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
-
1996
- 1996-05-08 US US08/639,968 patent/US5668151A/en not_active Expired - Fee Related
- 1996-05-22 CA CA002177110A patent/CA2177110A1/en not_active Abandoned
- 1996-06-05 DE DE69618383T patent/DE69618383T2/de not_active Expired - Fee Related
- 1996-06-05 AT AT96109043T patent/ATE211733T1/de not_active IP Right Cessation
- 1996-06-05 ES ES96109043T patent/ES2169774T3/es not_active Expired - Lifetime
- 1996-06-05 EP EP96109043A patent/EP0747357B1/de not_active Expired - Lifetime
- 1996-06-05 DK DK96109043T patent/DK0747357T3/da active
- 1996-06-05 PT PT96109043T patent/PT747357E/pt unknown
- 1996-06-06 AU AU54758/96A patent/AU720923B2/en not_active Ceased
- 1996-06-07 JP JP8145272A patent/JPH093045A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0747357A3 (de) | 1998-12-16 |
DE69618383T2 (de) | 2002-09-26 |
EP0747357A2 (de) | 1996-12-11 |
AU5475896A (en) | 1996-12-19 |
DK0747357T3 (da) | 2002-04-29 |
ES2169774T3 (es) | 2002-07-16 |
CA2177110A1 (en) | 1996-12-08 |
AU720923B2 (en) | 2000-06-15 |
US5668151A (en) | 1997-09-16 |
EP0747357B1 (de) | 2002-01-09 |
JPH093045A (ja) | 1997-01-07 |
PT747357E (pt) | 2002-06-28 |
ATE211733T1 (de) | 2002-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE211733T1 (de) | Dihydropyridine als npy-antagonisten: piperidinderivate | |
WO2001085098A3 (en) | Squarate derivatives of dihydropyridine npy antagonists | |
SE8701348L (sv) | Forbettringar av farmaceutiskt godtagabara salter | |
BR9811685A (pt) | Derivados de piridina | |
TR200000022T2 (tr) | 3-ya da 4-eşlenimli 4-(aminometil)-piperidin türevlerinin tek halkalı gastrokinetik benzamidleri. | |
BR9904998B1 (pt) | derivados de hidroxamida do ácido 5-oxo-pirrolidina-2-carboxìlico e composição farmacêutica. | |
EP0885192B8 (de) | Dihydropyridin-pyridin-, benzopyranon- und triazolochinazolin-derivate, deren herstellung und verwendung als adenosinrezeptor-antagonisten | |
KR970705556A (ko) | 알레르기성 질환 치료에 유용한 신규 치환된 피페리딘(Novel substituted piperidines useful for the treatment of allergic diseases) | |
HUP9701281A3 (en) | Piperidine derivatives as neurokinin antagonists and pharmaceutical compositions containing them | |
DE69326650T2 (de) | Piperidinderivate von Benzimidazole als antihistaminische und antiallergische Mittel | |
DE69616802T2 (de) | 1-(1,2-disubstituierte piperidinyl)-4-(kondensierte imidazole)-piperidin derivate | |
DK1077941T3 (da) | Forbindelser med væksthormonfrigörende egenskaber | |
DK135884A (da) | 1,4-dihydropyridin-forbindelser og farmaceutisk acceptable syreadditionssalte deraf og deres anvendelse som anti-ischaemiske og antihypertensive midler | |
TR28066A (tr) | 1,4-disübstitüe piperidin derivatlari, bunlarin hazirlanisi ve fungisid olarak kullanimi. | |
MX9302589A (es) | Procedimiento mejorado para la preparacion de derivados de n-metoxi de 4-hidroxi-2,2,6,6-tetrametilpiperidina y 2,2,6,6-tetrametil-4-piperidona. | |
WO1991018599A3 (de) | 1,4-dihydropyridine zur anwendung bei der überwindung von arzneimittelresistenzen | |
EA200000389A3 (ru) | Новые замещенные пиридины или пиперидины, способ их получения и содержащие их фармацевтические композиции | |
NO180779C (no) | Pyridinderivater, fremgangsmåte for deres fremstilling, anvendelse derav, sett omfattende slike, og utgangsforbindelse for fremgangsmåten | |
ES2012687A6 (es) | Procedimiento de preparacion de derivados 1,4-dihidro-piridinas. | |
BR9714081A (pt) | Processo para a cristalização do cloridrato de 1-[2-(2-naftil)etil]-4(3-trifluoro metilfenil)- 1,2,3,6- tetraidro piridina *sr 57746 a), formas i,ii e iii do mesmo, e, composição farmacêutica. | |
ATE126190T1 (de) | 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-5- | |
CA1262906C (en) | 3-(2-FUROYL)-5-ALCOXYCARBONYL-2,6-DIMETHYL-4-(2-NITROPHENYL)-1,4-DIHYDROPYRIDINES, CALCIUM ANTAGONISTS | |
SE8804436D0 (sv) | Trombolytiska och liknande sammansaettningar | |
KR900007831A (ko) | 1,4-디히드로피리딘 유도체 | |
DE3788738D1 (de) | Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |